Page last updated: 2024-09-03

tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and RF9

tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with RF9 in 1 studies

Compound Research Comparison

Studies
(tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide)
Trials
(tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide)
Recent Studies (post-2010)
(tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide)
Studies
(RF9)
Trials
(RF9)
Recent Studies (post-2010) (RF9)
80212010

Protein Interaction Comparison

ProteinTaxonomytyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide (IC50)RF9 (IC50)
KiSS-1 receptorHomo sapiens (human)0.83
Neuropeptide FF receptor 1Homo sapiens (human)0.41
Neuropeptide FF receptor 2Homo sapiens (human)0.41

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, JX; Marusich, J; Nguyen, T; Zhang, Y1

Other Studies

1 other study(ies) available for tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and RF9

ArticleYear
Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development.
    Journal of medicinal chemistry, 2020, 11-12, Volume: 63, Issue:21

    Topics: Analgesics, Opioid; Animals; Anxiety; Humans; Ligands; Mice; Oligopeptides; Pain; Peptidomimetics; Rats; Receptors, Neuropeptide; Small Molecule Libraries

2020